Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs

被引:47
|
作者
Chu, CA [1 ]
Sherck, SM [1 ]
Igawa, K [1 ]
Sindelar, DK [1 ]
Neal, DW [1 ]
Emshwiller, M [1 ]
Cherrington, AD [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA
关键词
free fatty acid; hyperglycemia; glycogenolysis; gluconeogenesis;
D O I
10.1152/ajpendo.00136.2001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to determine the effect of high levels of free fatty acids (FFA) and/or hyperglycemia on hepatic glycogenolysis and gluconeogenesis. Intralipid was infused peripherally in 18-h-fasted conscious dogs maintained on a pancreatic clamp in the presence (FFA + HG) or absence (FFA + EuG) of hyperglycemia. In the control studies, Intralipid was not infused, and euglycemia (EuG) or hyperglycemia (HG) was maintained. Insulin and glucagon were clamped at basal levels in all four groups. The arterial blood glucose level increased by 50% in the HG and FFA + HG groups. It did not change in the EuG and FFA + EuG groups. Arterial plasma FFA increased by similar to140% in the FFA + EuG and FFA + HG groups but did not change significantly either in the EuG or HG groups. Arterial glycerol levels increased by similar to150% in both groups. Overall (3-h) net hepatic glycogenolysis was 196 +/- 26 mg/kg in the EuG group. It decreased by 96 +/- 20, 82 +/- 16, and 177 +/- 22 mg/kg in the HG, FFA + EuG, and FFA + HG groups, respectively. Overall (3-h) hepatic gluconeogenic flux was 128 +/- 22 mg/kg in the EuG group, but it was suppressed by 30 +/- 9 mg/kg in response to hyperglycemia. It was increased by 59 +/- 12 and 56 +/- 10 mg/kg in the FFA + EuG and FFA + HG groups, respectively. In conclusion, an increase in plasma FFA and glycerol significantly inhibited hepatic glycogenolysis and markedly stimulated hepatic gluconeogenesis.
引用
收藏
页码:E402 / E411
页数:10
相关论文
共 50 条
  • [21] ROLE OF ENDOGENOUS FATTY-ACIDS IN THE CONTROL OF HEPATIC GLUCONEOGENESIS
    GONZALEZMANCHON, C
    MARTINREQUERO, A
    AYUSO, MS
    PARRILLA, R
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 292 (01) : 95 - 101
  • [22] Regulation of net hepatic glycogenolysis and gluconeogenesis by epinephrine in humans
    Dufour, Sylvie
    Lebon, Vincent
    Shulman, Gerald I.
    Petersen, Kitt Falk
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2009, 297 (01): : E231 - E235
  • [23] EFFECTS OF INSULIN AND FATTY ACIDS ON GLUCONEOGENESIS IN RAT
    FRIEDMAN.B
    GOODMAN, EH
    WEINHOUS.S
    FEDERATION PROCEEDINGS, 1966, 25 (2P1) : 347 - &
  • [24] EFFECTS OF INSULIN AND FATTY ACIDS ON GLUCONEOGENESIS IN RAT
    FRIEDMANN, B
    GOODMAN, EH
    WEINHOUSE, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1967, 242 (16) : 3620 - +
  • [25] Gluconeogenesis and hepatic glycogenolysis during exercise at the lactate threshold
    Emhoff, Chi-An W.
    Messonnier, Laurent A.
    Horning, Michael A.
    Fattor, Jill A.
    Carlson, Thomas J.
    Brooks, George A.
    FASEB JOURNAL, 2013, 27
  • [26] SOME HORMONAL INFLUENCES ON HEPATIC UPTAKE OF FREE FATTY ACIDS IN DIABETIC DOGS
    SPITZER, JJ
    MCELROY, WT
    DIABETES, 1962, 11 (03) : 222 - &
  • [27] SIMILAR DOSE RESPONSIVENESS OF HEPATIC GLYCOGENOLYSIS AND GLUCONEOGENESIS TO GLUCAGON
    STEVENSON, RW
    STEINER, K
    DAVIS, M
    HENDRICK, G
    WILLIAMS, P
    LACY, W
    CHERRINGTON, AD
    FEDERATION PROCEEDINGS, 1983, 42 (03) : 673 - 673
  • [28] Effects of energy restriction on lipolysis (lip), free fatty acid (FFA) fluxes, gluconeogenesis (GNG) and glycogenolysis in NIDDM.
    Christiansen, M
    Linfoot, P
    Neese, R
    Turner, S
    Hellerstein, M
    DIABETES, 1996, 45 : 1199 - 1199
  • [29] DIFFERENTIAL TIME COURSE OF GLUCAGONS EFFECT ON GLYCOGENOLYSIS AND GLUCONEOGENESIS IN THE CONSCIOUS DOG
    CHERRINGTON, AD
    WILLIAMS, PE
    SHULMAN, GI
    LACY, WW
    DIABETES, 1981, 30 (03) : 180 - 187
  • [30] Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes
    Boden, G
    Chen, XH
    Capulong, E
    Mozzoli, M
    DIABETES, 2001, 50 (04) : 810 - 816